bih.button.backtotop.text
BROWSE BY TEST NAME
%
1
2
3
5
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Clear
 
Test Code:
090-30-0082-01

Order Name:
HBsAg (Quantitative)

 
Useful For:
Determine the quantitative of hepatitis B surface antigen (HBsAg) in human serum.
 
Methodology:
Chemiluminescent Microparticle Immuno Assay (CMIA)
 
AliasesName:
Hepatitis B Surface Antigen (Quantitative) 
Hepatitis Bs Ag  (Quantitative) 
Hepatitis B Surface Ag (Quantitative) 
HBV surface antigen (Quantitative) 
 
 
 
Test Code:
090-30-0082-01

Order Name:
HBsAg (Quantitative)

 
Collection Specimen Or Container:
Blood/ Plain Blood (Red Top) 6 mL, 1 tube
 
Specimen Testing Type:
Serum, minimum volume 2 mL
 
Sub Mission Container:
Plastic vial
 
Rejection Criteria:
Hemolysis: 4+ reject
 
Specimen Stabillity:
Specimen Type Temperature Time
Serum (keep in original tube) Refrigerated, 2oC to 8oC 8 hours
Serum Refrigerated, 2oC to 8oC 14 days
Frozen, -20oC 1 month
 
 
 
Test Code:
090-30-0082-01

Order Name:
HBsAg (Quantitative)

 
Method detail:
Chemiluminescent Microparticle Immuno Assay (CMIA)
 
Schedule:
Tested daily (24 hours)
 
Turnaround Time:
Collected specimen to report within 2 hours (120 mins)
 
Performing Location:
Immunology, Laboratory Department Tel. 13227
 
Specimen Retention Time:
5 days
 
 
 
Test Code:
090-30-0082-01

Order Name:
HBsAg (Quantitative)

 
 
Clinical Information:
HBsAg assays are routinely used to aid in the diagnosis of suspected hepatitis B viral (HBV) infection and to monitor the status of infected individuals, i.e., whether the patient’s infection has resolved or the patient has become a chronic carrier of the virus. For the diagnosis of acute or chronic hepatitis, HBsAg reactivity should be correlated with patient history and the presence of other hepatitis B serological markers. Samples nonreactive by ARCHITECT HBsAg are considered negative for HBsAg and need not be tested further. A reactive sample must be retested in duplicate by ARCHITECT HBsAg to determine whether it is repeatedly reactive. A sample which is found to be repeatedly reactive should be confirmed by a neutralizing confirmatory test utilizing human anti-HBs, such as the ARCHITECT HBsAg Confirmatory assay. If the sample is neutralized, the sample is considered positive for HBsAg. It is recommended that confirmatory testing be performed prior to disclosure of HBV status. 
 
Reference Value:
Non reactive
 
Clinical Reference:
Manufacturer’s reagent package insert, Architect HBsAg, June 2015, Abbott Ireland Diagnostics Division, Finisklin Business Park, Sligo, Ireland.